Comprehensive Characterization of Swine Cardiac Troponin T Proteoforms by Top-Down Mass Spectrometry
- 677 Downloads
Cardiac troponin T (cTnT) regulates the Ca2+-mediated interaction between myosin thick filaments and actin thin filaments during cardiac contraction and relaxation. cTnT is released into the blood following injury, and increased serum levels of the protein are used clinically as a biomarker for myocardial infarction. Moreover, mutations in cTnT are causative in a number of familial cardiomyopathies. With the increasing use of large animal (swine) model to recapitulate human diseases, it is essential to characterize species-dependent protein sequence variants, alternative RNA splicing, and post-translational modifications (PTMs), but challenges remain due to the incomplete database and lack of validation of the predicted splicing isoforms. Herein, we integrated top-down mass spectrometry (MS) with online liquid chromatography (LC) and immunoaffinity purification to comprehensively characterize miniature swine cTnT proteoforms, including those arising from alternative RNA splicing and PTMs. A total of seven alternative splicing isoforms of cTnT were identified by LC/MS from swine left ventricular tissue, with each isoform containing un-phosphorylated and mono-phosphorylated proteoforms. The phosphorylation site was localized to Ser1 for the mono-phosphorylated proteoforms of cTnT1, 3, 4, and 6 by online MS/MS combining collisionally activated dissociation (CAD) and electron transfer dissociation (ETD). Offline MS/MS on Fourier-transform ion cyclotron resonance (FT-ICR) mass spectrometer with CAD and electron capture dissociation (ECD) was then utilized to achieve deep sequencing of mono-phosphorylated cTnT1 (35.2 kDa) with a high sequence coverage of 87%. Taken together, this study demonstrated the unique advantage of top-down MS in the comprehensive characterization of protein alternative splicing isoforms together with PTMs.
KeywordsCardiac troponin Heart disease Proteoform Top-down proteomics Collisionally activated dissociation Electron-transfer dissociation Electron-capture dissociation
Cardiac troponin (cTn) complex is a critical regulator that mediates the interaction between actin thin filaments and myosin thick filaments in cardiac muscle contraction and relaxation [1, 2, 3, 4, 5, 6]. There are three subunits in this complex named according to their functions: cardiac troponin C (cTnC, encoded by TNNC1 gene), the Ca2+ binding subunit; cardiac troponin I (cTnI, encoded by TNNI3 gene), the actomyosin ATPase inhibiting subunit; and cardiac troponin T (cTnT, encoded by TNNT2 gene), the tropomyosin-binding subunit. At low concentrations of intracellular Ca2+, cTn keeps tropomyosin in a position blocking the myosin interaction with actin; however, at increased levels of intracellular Ca2+, the allosteric conformational change in cTn-tropomyosin that occurs in response to Ca2+ binding exposes the myosin binding sites on the actin filaments and allows for actin-myosin interactions [2, 4]. Upon cardiac injury, cTn complexes are released into the circulation following cardiac cell necrosis [7, 8]. Both cTnT and cTnI are routinely tested as biomarkers in serum by an enzyme-linked immunosorbent assay with cardiac isoform-specific antibodies .
Among the three subunits, cTnT (30–35 kDa) has the most extensive alternative RNA splicing, resulting in a highly variable protein profile in different disease phenotypes . Mammalian cTnT RNA contains a total of 17 exons, three or more of which are known to be alternatively spliced . For human cTnT, four exons could be excluded from the complete RNA with exon 4 and exon 5 (fetal) coding sequences expressed near the N-terminus and exon 10 and exon 13 in the central region. The exclusion of one or more exons leads to 12 potential alternatively spliced isoforms expressed (P45379) according to the UniProtKB/Swiss-Prot database. Previous studies have shown that the increased exclusion or inclusion of sequences encoded by certain exons is associated with heart disease. For instance, an increase in cTnT isoforms lacking the exon 4 coding sequence could cause heart failure  and the re-expression of embryonic cTnT isoforms including exon 5 in the adult myocardium may contribute to the development of heart failure and reduced contractile efficiency [9, 10]. Furthermore, phosphorylation is the major post-translational modification (PTM) discovered and studied for cTnT . Previous studies have shown that phosphorylation of cTnT is regulated at multiple sites by a variety of kinases [6, 9, 11]. In addition to alternative splicing and PTMs, amino acid mutations in cTnT have been shown to be causative in hypertrophic, dilated, and restricted cardiomyopathies [4, 12, 13].
Recently, large animal models have been increasingly used to recapitulate human heart diseases and accelerate translational research [14, 15, 16]. Among them, domestic swine (Sus scrofa) is an exceedingly valuable model since swine hearts are very similar to those of humans in terms of anatomy and coronary artery distribution . In contrast to the conventional breeds of swine, which can typically reach 249–306 kg (550–675 lb.) and pose challenges in husbandry and handling in the biomedical research setting, the miniature swine typically weighs 68–91 kg (150–200 lb.) at equivalent maturity . Moreover, miniature swine breeds have the added advantage of slower growth curves and size similar to humans . At the protein level, the myofilament proteins in swine hearts have higher sequence homology to those of humans than rodents . However, because of the high genetic variability , the entries in the swine protein database such as cTnT are incomplete or have yet been validated, especially compared to the well-established human and rodent database. Thus, to fully realize the potential of swine heart model in cardiovascular research, it is essential to characterize cTnT sequence variants, alternative RNA splicing, as well as its PTMs.
The top-down mass spectrometry (MS)-based proteomics is arguably the most powerful method in characterizing proteoforms , which arise from sequence variations due to alternative splicing of the mRNA transcript and mutations/polymorphisms, as well as PTMs [1, 3, 5, 22, 23, 24, 25]. It provides a “bird’s-eye” view of all existing proteoforms by directly analyzing intact proteins after separation/purification. Ions from specific proteoforms can be subsequently isolated and subjected to multiple tandem MS (MS/MS) techniques for sequence mapping and modification localization . We have previously applied top-down proteomics to study the cardiac contractile proteins in vivo from human clinical samples and various animal models [5, 26, 27, 28, 29, 30, 31, 32, 33, 34, 35].
In this paper, we comprehensively characterized cTnT proteoforms from miniature swine left ventricle (LV) by employing a top-down LC/MS-based targeted proteomics approach coupled with immunoaffinity purification. We focused on LV because of its highly significant role in cardiac function by pumping oxygenated blood to tissues all over the body. LV dysfunction leads to congestive heart failure which is the final common pathway for various cardiac disorders . Various proteoforms arising from splicing events and PTMs were profiled by online liquid chromatography (LC)/MS with and without affinity purification. Seven alternatively spliced isoforms, all of which consist of un-phosphorylated and mono-phosphorylated proteoforms, were observed following affinity purification. Online MS/MS with collisionally activated dissociation (CAD) and electron transfer dissociation (ETD)  enabled the identification and characterization of cTnT proteoforms resulting from alternative splicing and PTMs. The phosphorylation site was localized to Ser1 for the mono-phosphorylated proteoforms investigated. The affinity purification largely alleviates the sample complexity after protein extraction and therefore facilitates the subsequent comprehensive proteoform characterization by LC/MS and MS/MS. Given the possibility of cTnT mutations throughout the backbone as well as its molecular weight over 30 kDa, offline CAD and electron capture dissociation (ECD) were then employed to achieve complete sequence coverage of the most abundant mono-phosphorylated proteoform.
All reagents were purchased from Sigma-Aldrich Inc. (St. Louis, MO, USA) unless noted otherwise. HPLC grade water, acetonitrile (ACN), ethanol (EtOH), and 98% formic acid (FA) were purchased from Fischer Scientific (Fair Lawn, NJ, USA).
Heart tissues were from the Wisconsin Miniature Swine  (WMS, around 6.5 months old) which were bred and maintained at the UW Swine Research and Teaching Center (Arlington, WI). The cardiac tissue excised from the left ventricle was immediately flash frozen in liquid nitrogen and stored in at − 80 °C.
Cardiac Troponin Complex Purification
Alternatively, myofilament proteins from the same miniature swine heart were extracted by HEPES and TFA buffers for individual cTnT profiling . In short, 5–10 mg of swine LV tissue was homogenized in 10 volumes (μL/mg tissue) of HEPES buffer (25 mM HEPES pH 7.5, 50 mM NaF, 2.5 mM EDTA, 1 mM PMSF, 1 mM Na3VO4) and centrifuged at 21,100 rcf for 30 min at 4 °C. The remaining pellet was further homogenized in 10 volumes of TFA solution (1% TFA, 2 mM TCEP) and centrifuged at 21,100 rcf for 45 min at 4 °C. The final supernatant was collected for direct LC/MS analysis.
Top-Down Analysis of Cardiac Troponin T
Immunoaffinity-purified swine cTn complex was desalted using a 10-kDa molecular weight cutoff filter with 0.1% FA in water. Online LC/MS analysis (Figure 1c) was carried out using a nanoAcquity ultra-high pressure LC system (Waters, Milford, MA, USA) coupled to high-resolution maXis II ETD and impact II quadrupole time-of-flight (Q-TOF) mass spectrometers (Bruker, Bremen, Germany). Five microliters of the desalted sample was loaded on a home-packed PLRP column (PLRP-S, 200 mm bed length, 0.5 mm i.d., 5 μm particle size, 1000 Å pore size, Agilent). Swine cTn subunits were eluted by a 60-min gradient of 5 to 95% mobile phase B (mobile phase A: 0.1% FA in water, mobile phase B: 0.1% FA in 50:50 ACN/EtOH) at a flow rate of 12 μL/min. Mass spectra were taken from maXis II ETD at a scan rate of 1 Hz over 500–3000 m/z range. TFA extracts were diluted 20 times and analyzed on impact II with the same parameters. Online targeted LC/MS/MS of CAD and ETD (Figure 1d) was performed on maXis II ETD with the selected charge states of mono-phosphorylated proteoforms (37+ to 44+) of cTnT1, cTnT3, cTnT4, and cTnT6 at 1 Hz over 200–2000 m/z range from the affinity purified samples. The isolation window was set to 3 m/z. The collision direct current (DC) bias was fixed to 14 V for CAD (nitrogen as collision gas). The precursor ion accumulation was set to 900 ms with a reagent (3,4-hexanedione) injection duration of 10 ms and an additional 2 ms reaction for ETD.
Offline MS/MS analysis (Figure 1e) of mono-phosphorylated cTnT1 deep sequencing was performed with direct infusion of the affinity-purified samples after desalting, mixed with two volumes of 0.1% FA in ACN on a 12-T solariX XR (Bruker, Bremen, Germany) Fourier-transform ion cyclotron resonance (FT-ICR) mass spectrometer equipped with a nano-electrospray ionization source (Triversa NanoMate, Advion BioSciences, Ithaca, NY). The size of transients was set to 2 M with the mass range of 200–2500 m/z (~ 2.2 s transient length) for all MS/MS experiments acquired on the Fourier-transform mass spectrometer Fourier-transform mass spectrometer (FTMS). Each MS/MS spectrum was the sum of 200–2000 transients. The isolation window was set to 3 m/z. The collision DC bias for CAD ranged from 7 to 15 V (Argon as collision gas), and the ECD bias was tested 0.2–0.8 V.
The LC/MS data was processed and analyzed using DataAnalysis software (Bruker Daltonics). Chromatograms shown were smoothened by Gauss algorithm with a smoothing width of 1.02 s. Mass spectra for swine cTnT proteoform profiling were deconvoluted using the Maximum Entropy algorithm incorporated in the DataAnalysis software. The resolving power for maximum entropy deconvolution was set to 80,000 for maXis II ETD and 50,000 for Impact II. Most abundant isotopomers of each proteoform were used to calculate the mass errors compared to the theoretical masses from cTnT sequences. All intact masses in this paper are reported as the most abundant masses, whereas all masses in MS/MS are reported as the monoisotopic masses for fragment assignment.
Online LC/MS/MS data was output as a .msalign file from the DataAnalysis software for cTnT identification using MS-Align+ . The swine protein database (34,524 entries) from UniProtKB/Swiss-Prot (download date 05/09/2017) together with the predicted swine cardiac cTnT alternative splicing isoforms from National Center for Biotechnology Information (NCBI, seven entries) was used for database searching. All fragments from both online and offline MS/MS were validated manually using MASH Suite Pro . Fragments of b, y, c, c-1, z●, and z● + 1 ions, using a tolerance of 15 ppm for the monoisotopic masses, were assigned after the validation (Figure 1f). For CAD experiments on mono-phosphorylated cTnT proteoforms, phosphorylation-preserved, loss of phosphorylation (− 80 Da), and loss of phosphate (− 98 Da) fragments were observed, whereas only phosphorylation-preserved fragments were detected for ETD and ECD experiments. Multiple spectra of CAD, ETD, and ECD experiments on different charge states were combined to reach the final sequence coverage.
Results and Discussion
LC/MS Analysis of Miniature Swine cTnT Proteoforms
Despite the observation of multiple cTnT proteoforms, it remained difficult to identify their sequences since none of the proteoform masses among cTnT1–7 matched any entry in the swine UniProtKB/Swiss-Prot database, even after considering potential modifications such as N-terminal Met truncation, N-terminal acetylation, and phosphorylation. Fortunately, we were able to find the model reference sequences based on computational predictions from NCBI nucleotide database that match the observed cTnT proteoforms. After N-terminal Met truncation, common acetylation observed at the new N-terminal Ser1 , and optional mono-phosphorylation, cTnT1, 2, 3, 4, and 6 have the same masses as alternative RNA splicing isoforms X1 (NM_001353839.1), X2 (NM_001353842.1), X3 (NM_001353844.1), X4 (NM_001353845.1), and X6 (NM_001257353.1), respectively, currently available in the database, while cTnT5 and 7 matched X5 (XM_013980114.1) and X7 (XM_013980115.1), respectively, based on the previous Sus scrofa build 4.3 . The alignment of these alternatively spliced sequences with in vivo human and mouse cTnT isoforms previously reported  is included in Figure S3. The sequences of cTnT among mouse, swine, and human have high homology (79.9% overall; Figure S3), where the most abundant swine cTnT isoform 1 shows higher sequence homology with that of human (88.2%, swine cTnT1 vs. human cTnT6), compared to that of mouse (86.9%, mouse cTnT3 vs. human cTnT6). Figure 2c shows the top four alternative splicing isoforms with the highest MS intensities and their corresponding un-phosphorylated and mono-phosphorylated proteoform masses within 1 ppm error from the theoretical values. Some minor non-covalent adducts and neutral losses also exist as labeled in Figure 2c. The complete list of identified swine cTnT proteoforms is found in Table S1 by accurate mass match. This is the first time that multiple isoforms of cTnT were confirmed in miniature swine LV tissue. However, there might be isoform heterogeneity (in terms of species and relative abundances) in different chambers, which necessitates further investigation. It is also noteworthy that although the MS intensities of cTnT isoforms from alternative RNA splicing could reflect their relative abundances, the quantification by directly comparing MS intensities within the sample might not be accurate since the polarity, electrospray ionization efficiency, and MS detection from different alternatively spliced isoforms can be significantly altered by the exclusion of sequences encoded by multiple exons.
We next investigated if these isoforms can be detected without the affinity purification (HEPES and TFA extraction protocol ). We used cTnT of the same LV tissue to compare the two methods. The cTnT1, 3, 4, and 6 proteoform patterns in Figure S4 by direct LC/MS analysis of the myofilament extract are highly consistent with those after the affinity purification (Figure 2b) in terms of the relative MS intensities of both alternative splicing sets and their phosphorylation levels, proving that the immunoaffinity purification successfully captured the major cTnT proteoforms without bias. Meanwhile, the complexity was greatly reduced after the purification compared to the whole myofilament subproteome extract (LC chromatograms; Figure 2a vs Figure S4a). As a result, the signal to noise ratios (S/N) of mutually observed cTnT proteoforms were higher and low abundant isoforms cTnT2, 5, and 7 excluding exon 13 coding sequence were only detected after the affinity purification. Direct online LC/MS of the myofilament extract is suitable for the screening purpose of abundant proteoforms with limited amounts of samples (~ 5 mg), whereas the immunoaffinity purification allows for the detection of cTnT proteoforms of low abundances.
Characterization of Mono-phosphorylated cTnT Proteoforms
Therefore, we performed the complementary CAD experiments on the mono-phosphorylated cTnT1, 3, 4, and 6. The energy transfer process via collisions in CAD cleaves the weakest peptide bonds, resulting in b and y fragment ions in proteins and peptides [1, 44]. For labile modification like phosphorylation, phosphate neutral loss (-H3PO4, 98 Da) exclusively occurs during CAD of small peptides . In the case of intact proteins on the other hand, phosphorylation could be partially preserved in the fragmentation process . Moreover, the formation of b ions introduces a carbonyl cation (C≡O+) [1, 44] that could potentially mitigate the lack of positive charge sites close to N-terminus. Indeed, a series of singly charged phosphorylation-preserved and phosphate-lost (− 98 Da) b ions were observed among CAD fragments for mono-phosphorylated cTnT1, 3, 4, and 6, accompanied by minor phosphorylation loss (-HPO3, 80 Da) shown in Figure 3. The presence of phosphorylated b ions very close to the N-terminus, for example, mono-phosphorylated b3, b4, b5 for cTnT1, 3, 4, and mono-phosphorylated b4, b5 for cTnT6, indicates that the acetylated terminal Ser1 is phosphorylated, given that it is the only potential phosphorylation site among the first five amino acid residues in each alternatively spliced isoform.
Furthermore, we also observed large y ions by peptide bond cleavages in exon 2 and 5 encoded regions for mono-phosphorylated cTnT1, 4, and 6. The representative y290 (cTnT1), y282 (cTnT4), and y277 (cTnT6) ions (Figure 3) are all un-phosphorylated absent of the corresponding mono-phosphorylated species or their potential phosphate loss (− 98 Da) forms, which confirm that there is minimum phosphorylation from Thr6 to the C-terminus. The evidences prove that Ser1 is predominantly phosphorylated for swine mono-phosphorylated cTnT1, 4, and 6, in agreement with the previous results that Ser1 was identified as the nearly exclusive phosphorylation site in human and mouse cTnT in vivo . CAD of mono-phosphorylated cTnT3 yielded small phosphorylated b ions to confirm Ser1 as one major phosphorylation site but did not produce large detectable y ions to exclude other possible phosphorylation sites, due to the low precursor ion intensity with clean isolation as it was co-eluted with cTnT4. Overall, the sequence coverages of cTnT1, 3, 4, and 6 combining online ETD and CAD are 27, 16, 24, and 30%, respectively.
Other proteoforms cTnT2, 5, and 7 were too low in abundances (Figure 2; Figure S2) for MS/MS. Yet, the major phosphorylation sites of cTnT2, 3, 5, and 7 are most likely to be Ser1 based on the sequence homology of these alternative RNA splicing isoforms (Figure S3). The conserved phosphorylation site on Ser1 of swine cTnT is consistent with its well-known structure of extended N-terminal , which can be directly accessed by kinases. Other identified phosphorylation sites by multiple kinases from in vitro and ex vivo tests could be specific to diseased cardiomyocytes . It is also possible that the occupancies of other sites in vivo for healthy hearts are extremely low (i.e., ~ 1%), which is beyond the detection limit of the current method. We have also observed that HPO3 loss occurred for the b ions during CAD of cTnT isoforms, consistent with those in human and mouse . Such fragments were predominantly observed in the case of human cTnI (Ser22, 23) . However, the fragmentation involving phosphorylation in different regions might depend on their individual sequences which require a further systematic investigation.
Deep Sequencing of Mono-phosphorylated cTnT1
However, there were still no fragment ions detected close to the N-terminus as ECD and ETD share similar fragmentation mechanisms . Thus, we adapted offline CAD to acquire fragments in this region. The phosphorylation-preserved and phosphate-lost (-H3PO4) b ions were constantly found in offline CAD (Figure S7) with multiple collision energies of the same precursor ions (charge state 29+, m/z 1215.1), accompanied by some minor phosphorylation-lost (-HPO3) b ions. Both phosphorylation-preserved and phosphate-lost fragments are informative in locating the phosphorylation site; the neutral loss of HPO3, nevertheless, generated fragments that could not be differentiated from those resulting from fragmentation of un-phosphorylated cTnT1. Only phosphorylation-preserved and phosphate-lost b ions are then compared in Figure 4c–e. More phosphorylation-preserved b ions were produced at a collision energy of 7.0 V in terms of both cleavage sites and relative abundances, whereas phosphate-lost fragments dominated b ions at 15 V. For y ions, all fragments were in un-phosphorylated form as the exclusive phosphorylation site has been pinpointed to Ser1 (Figs. 3 and 4). A variety of large y ions were generated at 7.0 V, whereas fragments of y ions in the sequence encoded by exon 6 were favored when the collision energy increased. More y ions closer to the C-terminus also occurred in 10 and 15 V experiments.
Here, our top-down MS/MS data unambiguously identified the phosphorylation site at Ser1, which is consistent with our previous studies which also unequivocally identified Ser1, as the phosphorylation for human, and mouse cTnT . Owing to its highly charged residues, the N-terminal region of cTnT adopts an extended conformation so that Ser1 residue can be easily accessible to kinase activities. Early studies on cTnT also determined that Ser1 was the predominant phosphorylation site in rabbit fast skeletal TnT and bovine cTnT [48, 49]. This demonstrates that phosphorylation of Ser1 (or Ser2 if taking in consideration of the N-terminal Met which was removed post-translationally) is highly conserved among different species. Nevertheless, the specific kinase responsible for Ser 1 phosphorylation and its physiological role remain enigmas .
In addition to Ser 1, previous studies have shown that phosphorylation of cTnT is regulated at multiple sites by a variety of kinases, such as Thr197, Ser201, Thr206, and Thr287 by protein kinase C (PKC) , Ser278 and Thr287 by Rho-A-dependent protein kinase (ROCK-II) , Thr197 and Ser201 by apoptosis signal-regulating kinase (ASK-1) , and Thr206 by Raf-1 . Phosphorylation related to PKC is believed to be critical in the development of cardiac hypertrophy or heart failure based predominantly on in vitro and ex vivo results . However, these phosphorylation sites in its central and C-terminal regions are not well conserved among different species and questions remain whether they are phosphorylated in vivo under physiological conditions .
In summary, we have comprehensively characterized the miniature swine LV cTnT proteoforms in terms of alternative splicing, phosphorylation, and deep sequencing using targeted top-down proteomics. Seven alternative RNA splicing isoforms, un-phosphorylated and mono-phosphorylated cTnT1–7, were observed and identified by online LC/MS integrated with immunoaffinity purification. cTnT1 remained the most abundant alternatively spliced isoform in miniature swine LV at 6.5 months old. cTnT5 and 7 of low abundances were only observed after the affinity purification with lower complexity compared to the whole myofilament extract. Phosphorylation, the main PTM of cTnT, was unambiguously localized to Ser1 of cTnT1, 4, and 6 according to online LC/MS/MS ETD and CAD results. The major phosphorylate sites of cTnT2, 3, 5, and 7 are most likely to be Ser1 based on sequence homology. Finally, by varying electron and collision energy in ECD and CAD, respectively, mono-phosphorylated cTnT1 was deep sequenced via offline MS/MS to achieve a sequence coverage of 87%. Any potential abundant cTnT sequence variations or modifications could be characterized with such high sequence coverage. Given the ample genetic diversity of miniature swine, cTnT isoform and PTM heterogeneity could arise from differences in various factors, including pedigree of breeds, age, anatomical location (e.g., different cardiac chambers), and disease status of the animals. Therefore, a systematic investigation on isoform switching and PTM changes should be conducted in the future work.
This work is dedicated to Professor Catherine E. Costello, the recipient of the 2017 Award for a Distinguished Contribution in Mass Spectrometry for her pioneering contributions to the development of tandem mass spectrometry of glycans and glycoconjugates. We would like to thank Bifan Chen for critical reading of this manuscript.
Financial support was kindly provided by NIH R01 HL109810 and HL096971 (to Y.G.). Y. G. would like to acknowledge NIH R01 GM117058 and S10 OD018475.
Compliance with Ethical Standards
All procedures were performed in accordance with the NIH Guide for the Care and Use of Laboratory Animals with protocols approved by the Animal Care and Use Committee of University of Wisconsin.
- 10.Feng, H.Z., Jin, J.P.: Coexistence of cardiac troponin T variants reduces heart efficiency. Am. J. Phys. Heart Circ. Phys. 299, H97–H105 (2010)Google Scholar
- 14.Ye, L., Chang, Y.H., Xiong, Q., Zhang, P.Y., Zhang, L.Y., Somasundaram, P., Lepley, M., Swingen, C., Su, L.P., Wendel, J.S., Guo, J., Jang, A., Rosenbush, D., Greder, L., Dutton, J.R., Zhang, J.H., Kamp, T.J., Kaufman, D.S., Ge, Y., Zhang, J.Y.: Cardiac repair in a porcine model of acute myocardial infarction with human induced pluripotent stem cell-derived cardiovascular cells. Cell Stem Cell. 15, 750–761 (2014)CrossRefGoogle Scholar
- 18.Dominic, T.S., Armando, T., Jennifer, J.M., Dane, A.B., Krista, N.D., Folagbayi, K.A., Joan, W., Serge, D.R., Dhanansayan, S.: Miniature swine for preclinical modeling of complexities of human disease for translational scientific discovery and accelerated development of therapies and medical devices. Toxicol. Pathol. 44, 299–314 (2016)CrossRefGoogle Scholar
- 19.Hamdani, N., de Waard, M., Messer, A.E., Boontje, N.M., Kooij, V., van Dijk, S., Versteilen, A., Lamberts, R., Merkus, D., dos Remedios, C., Duncker, D.J., Borbely, A., Papp, Z., Paulus, W., Stienen, G.J.M., Marston, S.B., van der Velden, J.: Myofilament dysfunction in cardiac disease from mice to men. J. Muscle Res. Cell Motil. 29, 189–201 (2008)CrossRefGoogle Scholar
- 22.Ansong, C., Wu, S., Meng, D., Liu, X., Brewer, H.M., Deatherage Kaiser, B.L., Nakayasu, E.S., Cort, J.R., Pevzner, P., Smith, R.D., Heffron, F., Adkins, J.N., Pasa-Tolic, L.: Top-down proteomics reveals a unique protein S-thiolation switch in Salmonella typhimurium in response to infection-like conditions. Proc. Natl. Acad. Sci. U. S. A. 110, 10153–10158 (2013)CrossRefGoogle Scholar
- 25.Tran, J.C., Zamdborg, L., Ahlf, D.R., Lee, J.E., Catherman, A.D., Durbin, K.R., Tipton, J.D., Vellaichamy, A., Kellie, J.F., Li, M., Wu, C., Sweet, S.M., Early, B.P., Siuti, N., LeDuc, R.D., Compton, P.D., Thomas, P.M., Kelleher, N.L.: Mapping intact protein isoforms in discovery mode using top-down proteomics. Nature. 480, 254–258 (2011)CrossRefGoogle Scholar
- 26.Ayaz-Guner, S., Zhang, J., Li, L., Walker, J.W., Ge, Y.: In vivo phosphorylation site mapping in mouse cardiac troponin I by high resolution top-down electron capture dissociation mass spectrometry: Ser22/23 are the only sites basally phosphorylated. Biochemistry. 48, 8161–8170 (2009)CrossRefGoogle Scholar
- 30.Peng, Y., Gregorich, Z.R., Valeja, S.G., Zhang, H., Cai, W.X., Chen, Y.C., Guner, H., Chen, A.J., Schwahn, D.J., Hacker, T.A., Liu, X.W., Ge, Y.: Top-down proteomics reveals concerted reductions in myofilament and Z-disc protein phosphorylation after acute myocardial infarction. Mol. Cell. Proteomics. 13, 2752–2764 (2014)CrossRefGoogle Scholar
- 31.Zhang, J., Guy, M.J., Norman, H.S., Chen, Y.C., Xu, Q.G., Dong, X.T., Guner, H., Wang, S.J., Kohmoto, T., Young, K.H., Moss, R.L., Ge, Y.: Top-down quantitative proteomics identified phosphorylation of cardiac troponin I as a candidate biomarker for chronic heart failure. J. Proteome Res. 10, 4054–4065 (2011)CrossRefGoogle Scholar
- 41.Pruitt, K., Brown, G., Tatusova, T., et al.: The Reference Sequence (RefSeq) Database. 2002 Oct 9 [Updated 2012 Apr 6]. In: McEntyre J, Ostell J, editors. The NCBI Handbook [Internet]. Bethesda (MD): National Center for Biotechnology Information (US); 2002-. Chapter 18. Available from: https://www.ncbi.nlm.nih.gov/books/NBK21091/
- 51.Sumandea, M.P., deTombe, P.P., Solaro, R.J.: PKC dependent regulation of myofilament function through cardiac troponin T phosphorylation. Circulation. 108, 125–125 (2003)Google Scholar